Specifically, SLE patients in the third tercile of leukocytes exhibited significantly elevated values of C4, C1-inhibitor, C3, factor D, and functional levels of the alternative pathway, after adjusting for confounding factors. The gene discussed is LIF; the disease is systemic lupus erythematosus.